Literature DB >> 177902

Rapid eye movement sleep alterations in myasthenia gravis.

O Papazian.   

Abstract

The nocturnal sleep patterns of 10 patients with myasthenia gravis and five controls were recorded in the conventional manner for 7 hours on two consecutive nights. One patient was retested 4 weeks after institution of prednisone therapy. All the myasthenics had a significant disturbance in rapid eye movement (REM) sleep cycles. In the patient who was retested after clinically successful prednisone therapy, the REM sleep pattern had become normal. Since acetylcholine is the putative brain stem transmitter substance involved in the maintenance of REM sleep, our findings suggest a disturbed central mechanism of acetylcholine in myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177902     DOI: 10.1212/wnl.26.4.311

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Disorders of Sleep and Breathing during Sleep in Neuromuscular Disease.

Authors:  Erik Van Lunteren; Henry J. Kaminski
Journal:  Sleep Breath       Date:  1999       Impact factor: 2.816

2.  Interactions of antinicotinic acetylcholine receptor antibodies with rat brain and muscle antigenic determinants.

Authors:  R J Lukas
Journal:  Cell Mol Neurobiol       Date:  1986-09       Impact factor: 5.046

3.  Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody.

Authors:  M Halbach; V Hömberg; H J Freund
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

Review 4.  Pain, Headache, and Other Non-motor Symptoms in Myasthenia Gravis.

Authors:  Olivia Tong; Leslie Delfiner; Steven Herskovitz
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

5.  Absence of central functional cholinergic deficits in myasthenia gravis.

Authors:  S W Lewis; M A Ron; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

6.  Neuropsychological assessment in myasthenia gravis.

Authors:  Emilia J Sitek; Małgorzata M Bilińska; Dariusz Wieczorek; Walenty M Nyka
Journal:  Neurol Sci       Date:  2009-01-16       Impact factor: 3.307

Review 7.  Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment.

Authors:  Isin Baral Kulaksizoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Sleep disorders in patients with myasthenia gravis: a systematic review.

Authors:  Ezequiel Fernandes Oliveira; Sergio R Nacif; Nixon Alves Pereira; Nina Teixeira Fonseca; Jéssica Julioti Urbano; Eduardo Araújo Perez; Valéria Cavalcante; Claudia Santos Oliveira; Giuseppe Insalaco; Acary Sousa Bulle Oliveira; Luis Vicente Franco Oliveira
Journal:  J Phys Ther Sci       Date:  2015-06-30

9.  Fatigue in myasthenia gravis: is it more than muscular weakness?

Authors:  Ahmed Elsais; Vegard B Wyller; Jon Håvard Loge; Emilia Kerty
Journal:  BMC Neurol       Date:  2013-10-03       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.